Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 38.6042.8044.0343.8746.15

What is the latest Core EBITDA Margin ratio of SUVEN PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of SUVEN PHARMACEUTICALS is 38.60 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202438.60
Mar202342.80
Mar202244.03
Mar202143.87
Mar202046.15

How is Core EBITDA Margin of SUVEN PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 38.6
-9.81
Mar2023 42.8
-2.79
Mar2022 44.03
0.36
Mar2021 43.87
-4.94
Mar2020 46.15 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹26,432.6 Cr 3.3% -7.6% 48.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,744.0 Cr -4.2% -7.7% 24.1% Stock Analytics
DIVIS LABORATORIES ₹152,209.0 Cr -0.6% -5.6% 57.5% Stock Analytics
CIPLA ₹117,762.0 Cr 3.3% -4.8% 6.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,705.3 Cr -2.4% -12.8% 1.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,929.3 Cr -0.3% -2.1% 24.5% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

3.3%

-7.6%

48.2%

SENSEX

0.3%

-1.8%

8.6%


You may also like the below Video Courses